The currently available antiviral treatments (Peg-Interferon-α and Nucleos(t)ide Analogues, NA) for chronic hepatitis B (CHB) achieve a functional cure (serum HBsAg and HDV-DNA clearance) of HBV infection in a limited number of patients. Nevertheless, the continuous pharmacological suppression of viral replication by NA halts liver disease progression lowering the risk of HCC development and improving the survival. In the near future, to fully exploit the potential of old and new drugs for HBV treatment a personalized approach to the patients will be required according to an accurate definition of their virologic, immunologic and clinical profile.
All Keywords
【저자키워드】 Antiviral treatment, HBV, Interferon-α, Chronic Hepatitis B, HBV functional cure, nucleos(t)ide analogues,
【저자키워드】 Antiviral treatment, HBV, Interferon-α, Chronic Hepatitis B, HBV functional cure, nucleos(t)ide analogues,